Details of the Drug Reposition

General Information of This Drug (ID: DMLFSMX)

Drug Name
GK1-399   DMLFSMX
Synonyms TTP-399

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Type-2 diabetes DIS3X247 5A11 Phase 2 [1]
Diabetic complication DIS4S2FC 5A2Y Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02405260) Add Glucokinase Activator to Target A1c. U.S. National Institutes of Health.